Literature DB >> 23892539

Deciphering the role of stroma in pancreatic cancer.

Meghna Waghray1, Malica Yalamanchili, Marina Pasca di Magliano, Diane M Simeone.   

Abstract

PURPOSE OF REVIEW: This review intends to describe recent studies on pancreatic tumor-associated stroma and potential opportunities and limitations to its targeting. RECENT
FINDINGS: One of the defining features of pancreatic cancer is extensive desmoplasia, or an inflammatory, fibrotic reaction. Carcinoma cells live in this complex microenvironment which is comprised of extracellular matrix (ECM), diffusible growth factors, cytokines and a variety of nonepithelial cell types including endothelial cells, immune cells, fibroblasts, myofibroblasts and stellate cells. In addition to the heterogeneity noted in the nonneoplastic cells within the tumor microenvironment, it has also been recognized that neoplastic cancer cells themselves are heterogeneous, and include a subpopulation of stem-cell like cells within tumors termed cancer stem cells. Due to the failure of current therapeutics to improve outcomes in patients with pancreatic cancer, new therapeutic avenues targeting different components of the tumor microenvironment are being investigated. In this review article, we will focus on recent studies regarding the function of the tumor stroma in pancreatic cancer and therapeutic treatments that are being advanced to target the stroma as a critical part of tumor management.
SUMMARY: Recent studies have shed new light on the contribution of the pancreatic cancer fibroinflammatory stroma to pancreatic cancer biology. Additional studies are needed to better define its full contribution to tumor behavior and how to best understand the optimal ways to develop therapies that counteract its pro-neoplastic properties.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23892539      PMCID: PMC4112589          DOI: 10.1097/MOG.0b013e328363affe

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  58 in total

1.  A phase II trial of nab-Paclitaxel as second-line therapy in patients with advanced pancreatic cancer.

Authors:  Peter J Hosein; Gilberto de Lima Lopes; Vitor H Pastorini; Christina Gomez; Jessica Macintyre; Gloria Zayas; Isildinha Reis; Alberto J Montero; Jaime R Merchan; Caio M Rocha Lima
Journal:  Am J Clin Oncol       Date:  2013-04       Impact factor: 2.339

2.  Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth.

Authors:  Matthew R Porembka; Jonathan B Mitchem; Brian A Belt; Chyi-Song Hsieh; Hyang-Mi Lee; John Herndon; William E Gillanders; David C Linehan; Peter Goedegebuure
Journal:  Cancer Immunol Immunother       Date:  2012-01-04       Impact factor: 6.968

Review 3.  FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicity.

Authors:  Krishna S Gunturu; Xiaopan Yao; Xiangyu Cong; Jaykumar R Thumar; Howard S Hochster; Stacey M Stein; Jill Lacy
Journal:  Med Oncol       Date:  2012-12-28       Impact factor: 3.064

4.  TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells.

Authors:  M R Moniri; X-Y Sun; J Rayat; D Dai; Z Ao; Z He; C B Verchere; L-J Dai; G L Warnock
Journal:  Cancer Gene Ther       Date:  2012-07-06       Impact factor: 5.987

5.  Pancreatic stellate cells enhance stem cell-like phenotypes in pancreatic cancer cells.

Authors:  Shin Hamada; Atsushi Masamune; Tetsuya Takikawa; Noriaki Suzuki; Kazuhiro Kikuta; Morihisa Hirota; Hirofumi Hamada; Masayoshi Kobune; Kennichi Satoh; Tooru Shimosegawa
Journal:  Biochem Biophys Res Commun       Date:  2012-04-09       Impact factor: 3.575

6.  Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer.

Authors:  Lauren J Bayne; Gregory L Beatty; Nirag Jhala; Carolyn E Clark; Andrew D Rhim; Ben Z Stanger; Robert H Vonderheide
Journal:  Cancer Cell       Date:  2012-06-12       Impact factor: 31.743

7.  Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells.

Authors:  Shingo Kozono; Kenoki Ohuchida; Daiki Eguchi; Naoki Ikenaga; Kenji Fujiwara; Lin Cui; Kazuhiro Mizumoto; Masao Tanaka
Journal:  Cancer Res       Date:  2013-01-24       Impact factor: 12.701

8.  Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes.

Authors:  Andrew V Biankin; Nicola Waddell; Karin S Kassahn; Marie-Claude Gingras; Lakshmi B Muthuswamy; Amber L Johns; David K Miller; Peter J Wilson; Ann-Marie Patch; Jianmin Wu; David K Chang; Mark J Cowley; Brooke B Gardiner; Sarah Song; Ivon Harliwong; Senel Idrisoglu; Craig Nourse; Ehsan Nourbakhsh; Suzanne Manning; Shivangi Wani; Milena Gongora; Marina Pajic; Christopher J Scarlett; Anthony J Gill; Andreia V Pinho; Ilse Rooman; Matthew Anderson; Oliver Holmes; Conrad Leonard; Darrin Taylor; Scott Wood; Qinying Xu; Katia Nones; J Lynn Fink; Angelika Christ; Tim Bruxner; Nicole Cloonan; Gabriel Kolle; Felicity Newell; Mark Pinese; R Scott Mead; Jeremy L Humphris; Warren Kaplan; Marc D Jones; Emily K Colvin; Adnan M Nagrial; Emily S Humphrey; Angela Chou; Venessa T Chin; Lorraine A Chantrill; Amanda Mawson; Jaswinder S Samra; James G Kench; Jessica A Lovell; Roger J Daly; Neil D Merrett; Christopher Toon; Krishna Epari; Nam Q Nguyen; Andrew Barbour; Nikolajs Zeps; Nipun Kakkar; Fengmei Zhao; Yuan Qing Wu; Min Wang; Donna M Muzny; William E Fisher; F Charles Brunicardi; Sally E Hodges; Jeffrey G Reid; Jennifer Drummond; Kyle Chang; Yi Han; Lora R Lewis; Huyen Dinh; Christian J Buhay; Timothy Beck; Lee Timms; Michelle Sam; Kimberly Begley; Andrew Brown; Deepa Pai; Ami Panchal; Nicholas Buchner; Richard De Borja; Robert E Denroche; Christina K Yung; Stefano Serra; Nicole Onetto; Debabrata Mukhopadhyay; Ming-Sound Tsao; Patricia A Shaw; Gloria M Petersen; Steven Gallinger; Ralph H Hruban; Anirban Maitra; Christine A Iacobuzio-Donahue; Richard D Schulick; Christopher L Wolfgang; Richard A Morgan; Rita T Lawlor; Paola Capelli; Vincenzo Corbo; Maria Scardoni; Giampaolo Tortora; Margaret A Tempero; Karen M Mann; Nancy A Jenkins; Pedro A Perez-Mancera; David J Adams; David A Largaespada; Lodewyk F A Wessels; Alistair G Rust; Lincoln D Stein; David A Tuveson; Neal G Copeland; Elizabeth A Musgrove; Aldo Scarpa; James R Eshleman; Thomas J Hudson; Robert L Sutherland; David A Wheeler; John V Pearson; John D McPherson; Richard A Gibbs; Sean M Grimmond
Journal:  Nature       Date:  2012-10-24       Impact factor: 49.962

9.  Mesenchymal stem cells regulate epithelial-mesenchymal transition and tumor progression of pancreatic cancer cells.

Authors:  Ayano Kabashima-Niibe; Hajime Higuchi; Hiromasa Takaishi; Yohei Masugi; Yumi Matsuzaki; Yo Mabuchi; Shinsuke Funakoshi; Masayuki Adachi; Yasuo Hamamoto; Shigeyuki Kawachi; Koichi Aiura; Yuko Kitagawa; Michiie Sakamoto; Toshifumi Hibi
Journal:  Cancer Sci       Date:  2013-01-11       Impact factor: 6.716

10.  Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer.

Authors:  Michael A Jacobetz; Derek S Chan; Albrecht Neesse; Tashinga E Bapiro; Natalie Cook; Kristopher K Frese; Christine Feig; Tomoaki Nakagawa; Meredith E Caldwell; Heather I Zecchini; Martijn P Lolkema; Ping Jiang; Anne Kultti; Curtis B Thompson; Daniel C Maneval; Duncan I Jodrell; Gregory I Frost; H M Shepard; Jeremy N Skepper; David A Tuveson
Journal:  Gut       Date:  2012-03-30       Impact factor: 23.059

View more
  64 in total

1.  A tumor vessel-targeting fusion protein elicits a chemotherapeutic bystander effect in pancreatic ductal adenocarcinoma.

Authors:  Chun-Te Chen; Yi-Chun Chen; Yi Du; Zhenbo Han; Haoqiang Ying; Richard R Bouchard; Jennifer L Hsu; Jung-Mao Hsu; Trevor M Mitcham; Mei-Kuang Chen; Hui-Lung Sun; Shih-Shin Chang; Donghui Li; Ping Chang; Ronald A DePinho; Mien-Chie Hung
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

2.  Cyclopamine-loaded core-cross-linked polymeric micelles enhance radiation response in pancreatic cancer and pancreatic stellate cells.

Authors:  Jun Zhao; Chunhui Wu; James Abbruzzese; Rosa F Hwang; Chun Li
Journal:  Mol Pharm       Date:  2015-05-12       Impact factor: 4.939

3.  Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts.

Authors:  Mohan Bolisetty; Pasquale Laise; William F Flynn; Ela Elyada; Elise T Courtois; Richard A Burkhart; Jonathan A Teinor; Pascal Belleau; Giulia Biffi; Matthew S Lucito; Santhosh Sivajothi; Todd D Armstrong; Dannielle D Engle; Kenneth H Yu; Yuan Hao; Christopher L Wolfgang; Youngkyu Park; Jonathan Preall; Elizabeth M Jaffee; Andrea Califano; Paul Robson; David A Tuveson
Journal:  Cancer Discov       Date:  2019-06-13       Impact factor: 39.397

4.  Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methylation.

Authors:  Qian Xiao; Donger Zhou; Agnieszka A Rucki; Jamila Williams; Jiaojiao Zhou; Guanglan Mo; Adrian Murphy; Kenji Fujiwara; Jennifer Kleponis; Bulent Salman; Christopher L Wolfgang; Robert A Anders; Shu Zheng; Elizabeth M Jaffee; Lei Zheng
Journal:  Cancer Res       Date:  2016-08-05       Impact factor: 12.701

Review 5.  Pancreatic biomarkers: could they be the answer?

Authors:  Angela Lamarca; Jaime Feliu
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

Review 6.  CAR T-cell therapy for pancreatic cancer.

Authors:  Carl J DeSelm; Zachary E Tano; Anna M Varghese; Prasad S Adusumilli
Journal:  J Surg Oncol       Date:  2017-03-27       Impact factor: 3.454

Review 7.  Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer.

Authors:  Guido Eibl; Zobeida Cruz-Monserrate; Murray Korc; Maxim S Petrov; Mark O Goodarzi; William E Fisher; Aida Habtezion; Aurelia Lugea; Stephen J Pandol; Phil A Hart; Dana K Andersen
Journal:  J Acad Nutr Diet       Date:  2017-09-12       Impact factor: 4.910

Review 8.  Immune Therapy in GI Malignancies: A Review.

Authors:  Judy Wang; Kim A Reiss; Rina Khatri; Elizabeth Jaffee; Dan Laheru
Journal:  J Clin Oncol       Date:  2015-04-27       Impact factor: 44.544

9.  Generation of an in vitro 3D PDAC stroma rich spheroid model.

Authors:  Matthew J Ware; Vazrik Keshishian; Justin J Law; Jason C Ho; Carlos A Favela; Paul Rees; Billie Smith; Sayeeduddin Mohammad; Rosa F Hwang; Kimal Rajapakshe; Cristian Coarfa; Shixia Huang; Dean P Edwards; Stuart J Corr; Biana Godin; Steven A Curley
Journal:  Biomaterials       Date:  2016-09-02       Impact factor: 12.479

Review 10.  Process of hepatic metastasis from pancreatic cancer: biology with clinical significance.

Authors:  Haojun Shi; Ji Li; Deliang Fu
Journal:  J Cancer Res Clin Oncol       Date:  2015-08-07       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.